Neogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings

04/07

Neogen Corporation (NASDAQ:NEOG) will release earnings for its third quarter before the opening bell on Thursday, April 9.

Analysts expect the Lansing, Michigan-based company to report quarterly earnings of 5 cents per share, down from 10 cents per share in the year-ago period. The consensus estimate for Neogen's quarterly revenue is $204.62 million (it reported $220.98 million last year), according to Benzinga Pro.

On March 2, Neogen announced the sale of Genomics business to Zoetis.

Neogen shares rose 1.6% to close at $9.56 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Piper Sandler analyst David Westenberg maintained a Neutral rating and raised the price target from $6.5 to $10 on Jan. 12, 2026. This analyst has an accuracy rate of 68%.
Guggenheim analyst Subbu Nambi maintained a Buy rating and increased the price target from $8 to $12 on Jan. 9, 2026. This analyst has an accuracy rate of 51%.
CJS Securities analyst Robert Labick upgraded the stock from Market Perform to Market Outperform and a price target of $10 on Dec. 10, 2025. This analyst has an accuracy rate of 68%.
William Blair analyst Brandon Vazquez downgraded the stock from Outperform to Market Perform on July 29, 2025. This analyst has an accuracy rate of 64%.

Considering buying NEOG stock? Here’s what analysts think:

Photo via Shutterstock

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2625934565"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2625934565\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2625934565?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-07 18:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625934565","market":"us","top_or_hot":-1,"title":"Neogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","media":"Benzinga Earnings","content":"<html><body><p><strong>Neogen Corporation</strong> (NASDAQ:NEOG) will release earnings for its third quarter before the opening bell on Thursday, April 9.</p>\n<p>Analysts expect the Lansing, Michigan-based company to report quarterly earnings of 5 cents per share, down from 10 cents per share in the year-ago period. The consensus estimate for Neogen's quarterly revenue is $204.62 million (it reported $220.98 million last year), according to Benzinga Pro.</p>\n<p>On March 2, Neogen announced the sale of Genomics business to Zoetis.</p>\n<p>Neogen shares rose 1.6% to close at $9.56 on Monday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Piper Sandler analyst David Westenberg maintained a Neutral rating and raised the price target from $6.5 to $10 on Jan. 12, 2026. This analyst has an accuracy rate of 68%.</li>\n<li>Guggenheim analyst Subbu Nambi maintained a Buy rating and increased the price target from $8 to $12 on Jan. 9, 2026. This analyst has an accuracy rate of 51%.</li>\n<li>CJS Securities analyst Robert Labick upgraded the stock from Market Perform to Market Outperform and a price target of $10 on Dec. 10, 2025. This analyst has an accuracy rate of 68%.</li>\n<li>William Blair analyst Brandon Vazquez downgraded the stock from Outperform to Market Perform on July 29, 2025. This analyst has an accuracy rate of 64%.</li>\n</ul>\n<p>Considering buying NEOG stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"521\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-1024x521.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-1024x521.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-768x391.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95.png 1218w\" width=\"1024\"/></figure>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time\">2026-04-07 18:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Neogen Corporation</strong> (NASDAQ:NEOG) will release earnings for its third quarter before the opening bell on Thursday, April 9.</p>\n<p>Analysts expect the Lansing, Michigan-based company to report quarterly earnings of 5 cents per share, down from 10 cents per share in the year-ago period. The consensus estimate for Neogen's quarterly revenue is $204.62 million (it reported $220.98 million last year), according to Benzinga Pro.</p>\n<p>On March 2, Neogen announced the sale of Genomics business to Zoetis.</p>\n<p>Neogen shares rose 1.6% to close at $9.56 on Monday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Piper Sandler analyst David Westenberg maintained a Neutral rating and raised the price target from $6.5 to $10 on Jan. 12, 2026. This analyst has an accuracy rate of 68%.</li>\n<li>Guggenheim analyst Subbu Nambi maintained a Buy rating and increased the price target from $8 to $12 on Jan. 9, 2026. This analyst has an accuracy rate of 51%.</li>\n<li>CJS Securities analyst Robert Labick upgraded the stock from Market Perform to Market Outperform and a price target of $10 on Dec. 10, 2025. This analyst has an accuracy rate of 68%.</li>\n<li>William Blair analyst Brandon Vazquez downgraded the stock from Outperform to Market Perform on July 29, 2025. This analyst has an accuracy rate of 64%.</li>\n</ul>\n<p>Considering buying NEOG stock? Here’s what analysts think: </p>\n<figure><img decoding=\"async\" height=\"521\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-1024x521.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-1024x521.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95-768x391.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/07033231/image-95.png 1218w\" width=\"1024\"/></figure>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/04/51674323/neogen-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","article_id":"2625934565","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2625934565","pubTimestamp":1775557926,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Neogen Corporation (NASDAQ: NEOG) to release Q3 earnings on April 9. Analysts expect 5 cents/share, down from 10 cents last year. Stock rose 1.6% on Monday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","NEOG":"纽尔真检测","LU2211817866.USD":"Allianz Food Security AT Acc USD"},"translate_title":"Neogen盈利迫在眉睫；这些最准确的分析师在收益看涨期权之前修改了预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NEOG":1},"content_text":"Neogen Corporation (NASDAQ:NEOG) will release earnings for its third quarter before the opening bell on Thursday, April 9.\nAnalysts expect the Lansing, Michigan-based company to report quarterly earnings of 5 cents per share, down from 10 cents per share in the year-ago period. The consensus estimate for Neogen's quarterly revenue is $204.62 million (it reported $220.98 million last year), according to Benzinga Pro.\nOn March 2, Neogen announced the sale of Genomics business to Zoetis.\nNeogen shares rose 1.6% to close at $9.56 on Monday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nPiper Sandler analyst David Westenberg maintained a Neutral rating and raised the price target from $6.5 to $10 on Jan. 12, 2026. This analyst has an accuracy rate of 68%.\nGuggenheim analyst Subbu Nambi maintained a Buy rating and increased the price target from $8 to $12 on Jan. 9, 2026. This analyst has an accuracy rate of 51%.\nCJS Securities analyst Robert Labick upgraded the stock from Market Perform to Market Outperform and a price target of $10 on Dec. 10, 2025. This analyst has an accuracy rate of 68%.\nWilliam Blair analyst Brandon Vazquez downgraded the stock from Outperform to Market Perform on July 29, 2025. This analyst has an accuracy rate of 64%.\n\nConsidering buying NEOG stock? Here’s what analysts think: \n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}